23Strands unlocks the power of DNA, providing insights into current and future best suited medication and disease risk based on DNA.
23Strands has raised $5.0M in total funding. The most recent round was Grant. The last funding was announced in February 2023.
23Strands's investors include Australian Medical Angels, UNSW Founders, National Health and Medical Research Council.
23Strands is headquartered in Pyrmont, Australia.
23Strands unlocks the power of DNA, providing insights into current and future best suited medication and disease risk based on DNA.
23Strands is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"23Strands — Funding & Investors." VCBacked, February 6, 2023, https://www.vcbacked.co/company/23strands. Accessed August 14, 2026.
VCBacked. (2023). 23Strands — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/23strands
{{cite web |title=23Strands — Funding & Investors |url=https://www.vcbacked.co/company/23strands |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated